Cargando…
Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin‐induced diabetic rats
Diabetic cardiomyopathy is characterized by diastolic and systolic cardiac dysfunction, yet no therapeutic drug to specifically treat it. Hexarelin has been demonstrated to improve heart function in various types of cardiomyopathy via its receptor GHS‐R. This experiment aims to test the effect of he...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812882/ https://www.ncbi.nlm.nih.gov/pubmed/29446246 http://dx.doi.org/10.14814/phy2.13612 |